Significance: A strong relationship between hyperglycemia, impaired insulin pathway, and cardiovascular disease in type 2 diabetes (T2D) is linked to oxidative stress and inflammation. Immunometabolic pathways link these pathogenic processes and pose important potential therapeutic targets. Recent Advances: The link between immunity and metabolism is bidirectional and includes the role of inflammation in the pathogenesis of metabolic disorders such as T2D, obesity, metabolic syndrome, and hypertension and the role of metabolic factors in regulation of immune cell functions. Low-grade inflammation, oxidative stress, balance between superoxide and nitric oxide, and the infiltration of macrophages, T cells, and B cells in insulin-sensitive tissues lead to metabolic impairment and accelerated aging. Critical Issues: Inflammatory infiltrate and altered immune cell phenotype precede development of metabolic disorders. Inflammatory changes are tightly linked to alterations in metabolic status and energy expenditure and are controlled by epigenetic mechanisms. Future Directions: A better comprehension of these mechanistic insights is of utmost importance to identify novel molecular targets. In this study, we describe a complex scenario of epigenetic changes and immunometabolism linking to diabetes and aging-associated vascular disease. © Tomasz J.
Epigenetics and immunometabolism in diabetes and aging / Guzik, ; Tomasz, J; Cosentino, Francesco. - In: ANTIOXIDANTS & REDOX SIGNALING. - ISSN 1523-0864. - STAMPA. - 29:3(2018), pp. 1-18. [10.1089/ars.2017.7299]
|Titolo:||Epigenetics and immunometabolism in diabetes and aging|
COSENTINO, Francesco (Corresponding author)
|Data di pubblicazione:||2018|
|Citazione:||Epigenetics and immunometabolism in diabetes and aging / Guzik, ; Tomasz, J; Cosentino, Francesco. - In: ANTIOXIDANTS & REDOX SIGNALING. - ISSN 1523-0864. - STAMPA. - 29:3(2018), pp. 1-18. [10.1089/ars.2017.7299]|
|Appartiene alla tipologia:||01a Articolo in rivista|